North America Narcolepsy Market to 2027 - Regional Analysis and Forecasts By Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy); Product (Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Country
North America narcolepsy market is anticipated to reach US$ 2,024.8 Mn in 2027 from US$ 919.6 Mn in 2018. The Narcolepsy market is expected to rise with a CAGR of 9.3% from 2019-2027.
The narcolepsy market is estimated to grow due to the key driving factors such as rising sleeping disorders and growing pharmaceutical industry. However, the market is expected to face restraining factors such as no cure treatment for narcolepsy
Narcolepsy is a disorder of chronic neurological disorder; the disorder impacts the brain’s ability to control sleep and wake-up cycle. A person can get affected by the disorder in childhood, young age, or in adulthood, which from 17 years to 25 years. The most widely seen symptoms seen are excessive daytime sleepiness, cataplexy, sleep paralysis, and hallucinations. The disorder is a frequent disorder among the people across the North American region and is the second leading cause of excessive daytime sleepiness. According to the National Organization for Rare Disorder, it is stated that the incidences of narcolepsy are 1 in 2,000. Similarly, as per the National Institute of Neurological Disorders and Stroke, it is estimated that across the United States, nearly 135,000 to 200,000 people are living narcolepsy.
The rise in sleep disorders is impacting the working efficiency of people, and it is also affecting the performance of children in the studies. Similarly, it is affecting older people. The disorder increases the risk as the age grows, and it may stop breathing activity during sleep time. According to the studies published by Oxford Academics in April 2018, it is stated that the incidences are widely seen among women. The study also stated that the incidences were higher among the people between 21–30 years of age group. It is also expected that narcolepsy is caused by environmental exposures before the age of beginning in genetically inclined individuals.
It is expected that the incidences of sleep disorders are likely to grow in the coming years. Sleep disorders have become a great concern among the people of the North American region. Over 50 million people in the region are suffering from more than 80 different sleep disorders, and nearly 20 to 30 million are living with recurrent sleep disorders every year. Thus, rising sleeping disorders are likely to demand treatment for narcolepsy, which will eventually lead to the growth of the market in the coming future.
US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
Get more information on this report :
North America Narcolepsy – Market Segmentation
North America Narcolepsy Market – By Type
- Narcolepsy with Cataplexy
- Narcolepsy without Cataplexy
- Secondary Narcolepsy
North America Market – By Product
- Central Nervous System (CNS) Stimulants
- Sodium Oxybate
- Antidepressants
North America Market – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
By Geography
- North America
- US
- Canada
- Mexico
Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Jazz Pharmaceuticals plc
- Arena Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- BIOPROJET
- Shionogi & Co., Ltd.
- Ligand Pharmaceuticals, Inc
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. North America Narcolepsy Market – Key Takeaways
3. North America Narcolepsy Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America Narcolepsy Market – By Type
3.2.2 North America Narcolepsy Market – By Product
3.2.3 North America Narcolepsy Market – By Distribution Channel
3.2.4 North America Narcolepsy Market – By Country
3.3 Pest Analysis
4. North America Narcolepsy Market-Key Dynamics
4.1 Key Market Drivers
4.1.1 Rising Sleep Disorders
4.1.2 Growing Pharmaceutical Industry
4.2 Key Market Restraints
4.2.1 No Cure Treatment for Narcolepsy
4.3 Key Market Opportunity
4.3.1 Awareness Programs for Narcolepsy
4.4 Future Trend
4.4.1 Developments in Pharmaceutical Sector to Treat Narcolepsy
4.5 Impact Analysis Of Drivers and Restraints
5. Narcolepsy Market – Regional Analysis
5.1 North America Narcolepsy Market Revenue Forecasts and Analysis
5.2 Performance Of Key Players
5.2.1 Jazz Pharmaceuticals plc
5.2.2 Teva Pharmaceutical Industries Ltd.
6. Narcolepsy Market Analysis and Forecasts to 2027 – Type
6.1 Overview
6.2 Type Market Revenue and Forecasts Analysis (US$ Mn)
6.3 North America Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (Us$ Mn)
6.4 Narcolepsy With Cataplexy Market
6.4.1 Overview
6.4.2 Narcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Narcolepsy Without Cataplexy Market
6.5.1 Overview
6.5.2 Narcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Secondary Narcolepsy Market
6.6.1 Overview
6.6.2 Secondary Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)
7. Narcolepsy Market Analysis and Forecasts to 2027 – Product
7.1 Overview
7.2 Product Market Revenue and Forecasts Analysis (US$ Mn)
7.3 North America Narcolespy Market Revenue and Forecasts To 2027, By Product (US$ Mn)
7.4 Central Nervous System Stimulants Market
7.4.1 Overview
7.4.2 Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Sodium Oxybate Market
7.5.1 Overview
7.5.2 Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Antidepressants Market
7.6.1 Overview
7.6.2 Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)
8. Narcolepsy Market Analysis and Forecasts to 2027 – Distribution Channel
8.1 Overview
8.2 Distribution Channel Market Revenue and Forecasts Analysis (US$ Mn)
8.3 North America Narcolespy Market Revenue and Forecasts To 2027, By End User (US$ Mn)
8.4 Hospital Pharmacies Market
8.4.1 Overview
8.4.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Retail Pharmacies Market
8.5.1 Overview
8.5.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9. Narcolepsy Market Revenue And Forecasts To 2027 – Geographical Analysis
9.1 North America Narcolepsy Market
9.1.1 Overview
9.1.2 North America Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 North America Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.4 North America Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.5 North America Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.6 North America Narcolepsy Market Revenue and Forecasts to 2027, By Country (%)
9.1.7 US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8 US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 US Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.2 US Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.8.3 US Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.9 Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10 Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.1 Canada Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.10.2 Canada Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.10.3 Canada Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.11 Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.12 Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.12.1 Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.12.2 Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.12.3 Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
10. Narcolepsy Market – Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done By The Companies In The Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Narcolepsy Market –Key Company Profiles
11.1 Teva Pharmaceutical Industries Ltd.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Jazz Pharmaceuticals Plc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Arena Pharmaceuticals, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Graymark Healthcare, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Information
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Information
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Takeda Pharmaceutical Company Limited
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Pipeline
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Mylan N.V.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Bioprojet
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Shionogi & Co., Ltd.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 Product Pipeline
11.9.6 SWOT Analysis
11.9.7 Key Developments
11.10 Ligand Pharmaceuticals, Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 Product Pipeline
11.10.6 SWOT Analysis
11.10.7 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. North America Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 2. North America Narcolepsy Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 3. North America Narcolepsy Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 4. North America Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 5. North America Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 6. North America Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 7. US Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 8. US Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 9. US Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 10. Canada Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 11. Canada Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 12. Canada Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 13. Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 14. Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 15. Mexico Narcolepsy Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 16. Organic Developments Done By Companies
Table 17. Inorganic Developments Done By Companies
Table 18. Glossary of Terms, Narcolepsy Market
LIST OF FIGURES
Figure 1. Us Narcolepsy Market, Revenue (Us$ Mn), 2018 & 2027
Figure 2. North America Narcolepsy Market By Type, Market Share (%), 2018
Figure 3. North America Narcolepsy Market By Product, Market Share (%), 2018
Figure 4. North America Narcolepsy Market By Distribution Channel, Market Share (%), 2018
Figure 5. Narcolepsy Market Segmentation
Figure 6. North America Pest Analysis
Figure 7. Narcolepsy Market Impact Analysis Of Drivers and Restraint
Figure 8. North America Narcolepsy Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 9. Type Market Analysis and Forecasts 2018 and 2027 (%)
Figure 10. Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 11. Narcolepsy Without Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 12. Secondary Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 13. Product MARKET Analysis and Forecasts 2018 and 2027 (%)
Figure 14. Central Nervous System Stimulants Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 15. Sodium Oxybate Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 16. Antidepressants Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 17. Distribution Channel Market Analysis and Forecasts 2018 and 2027 (%)
Figure 18. Hospital Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 19. Retail Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 20. North America Narcolepsy Market Revenue Overview, By Country (2018) (Us $ Mn)
Figure 21. North America Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 22. North America Narcolepsy Market Revenue and Forecasts To 2027, By Country (%)
Figure 23. US Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 24. Canada Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 25. Mexico Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 26. Comparative Company Analysis
Figure 27. Growth Strategies Done By The Companies In The Market, (%)
The List of Companies - North America Narcolepsy Market
- Teva Pharmaceutical Industries Ltd.
- Jazz Pharmaceuticals plc
- Arena Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- BIOPROJET
- Shionogi & Co., Ltd.
- Ligand Pharmaceuticals, Inc
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the North America narcolepsy market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.